Strong Revenue and EBITDA Growth
First quarter revenues increased by 10.6% to $1.46 billion, and adjusted EBITDA rose by 14.9% to $313.6 million.
Significant Discharge Growth
Total discharge growth was 6.3% in the first quarter, with same-store discharges growing by 4.4%.
High Occupancy and Expansion Plans
Occupancy rates reached a high of 78.8%, prompting plans to add approximately 120 beds in both 2026 and 2027 and 300 beds through 6 de novos in 2025.
Reduced Premium Labor Costs
Premium labor costs decreased by $5 million from Q1 2024 to $28.6 million, indicating improved labor efficiency.
Increased Free Cash Flow Guidance
Adjusted free cash flow increased by 32.7% to $222.4 million, and full-year guidance was raised to $620 million to $715 million.